503b glp 1 PSM submits comment supporting the continued exclusion of GLP-1s from the Bulks List – Partnership for Safe Medicines Wegovy (Semaglutide) GLP-1 injection Age_Range: 55-64 Concentration:30mg

503b glp 1 PSM submits comment supporting the continued exclusion of GLP-1s from the Bulks List – Partnership for Safe Medicines Wegovy (Semaglutide) GLP-1 injection Age_Range: 55-64 Concentration:30mg

Wegovy (Semaglutide) GLP-1 injection - Nurx™

Strict BP control is required for patients with T2D to prevent cardiovascular complications, however, the achievement rate of target BP in patients with T2D in clinical practice in Japan was low, at 36.7% in office and 24.4% at home [42]

Age_Range: 55-64

Concentration:30mg

The piece lays out a practical framework for turning those signals into pharmacist outreach and member support, with two guardrails I think matter more than the modeling: flags should trigger help rather than coverage restriction, and equity monitoring belongs in the design from the start, not bolted on after